DCLK1 and clear cell renal carcinoma: Herein, we reveal that DCLK1 is significantly activated, with a concomitant alternative-promoter model switch (β-to-α) towards the long variants (isoform 1 and 2) in clear cell renal cell carcinoma (ccRCC).